Enterobacteriaceae strains with reduced susceptibility to carbapenems
DOI:
https://doi.org/10.12775/MBS.2015.008Keywords
Enterobacteriaceae, carbepenem-resistant Enterobacteriaceae, reduced susceptibility to carbapenemsAbstract
The aim of the study was to estimate the prevalence of Enterobacteriaceae with reduced susceptibility to carbapenems. Forty-five strains of Enterobacteriaceae with reduced susceptibility to carbapenems were investigated. The strains were cultured from patients treated at the Dr Antoni Jurasz University Hospital no.1 in Bydgoszcz. Identification of the strains was carried out based on the results of biochemical reactions performed in identification cards GN (bioMérieux). Susceptibility testing to carbapenems and determining Minimal Inhibitory Concentration (MIC) was carried out using E - test (bioMérieux) (for ertapenem and imipenem), and agar dilution method for meropenem. The analysed strains were isolated from: urine – 13 strains (28.9%), blood and bronchoalveolar lavage - six strains from each (13.3% ), 5 – wound swabs (11.2%) and other clinical materials – 15 (33.3%). 53.3% of the strains were identified as Klebsiella pneumoniae. 93.4% of the isolates were susceptible to meropenem. Only 4.5% of the analysed strains were susceptible to ertapenem. None of the analyzed strains produced carbapenemases.
References
Paterson D.L., Resistance in gram-negative bacteria: Enterobacteriaceae, Am J Med., 2006, 119:20-28.
Yang Q., Wang H., Sun H., Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China, Antimicrob Agents Chemother., 2010, 54:573-577.
Patel N., Harrington S., Dihmess A., Clinical epidemiology of carbapenem-intermediate or –resistant Enterobacteriaceae. J Antimicrob Chemother., 2011, 66:1600-1608.
Davies T.A., Queenan A. M.A., Morrow B.J., Longtidunal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from USA in 2007-09, J Antimicrob. Chemother., 2011, 66: 2298-2307.
Schwaber M.J., Carmeli Y., Carbapenem-resistant Enterobacteriaceae: a potential threat, JAMA, 2008, 300:2911-2913.
Gupta N., Limbago B.M., Patel J.B., Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention, Clin Infect Dis., 2011, 53:60-67.
Schechner W., Kotlovsky T., Tarabeia J., Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter, Infect Contr Hosp Epidemiol., 2011, 32:497-503.
Lee G.C., Lawson K.A., Burgess D.S., Clinical epidemiology of carbapenem-resistant Enterobacteriaceae in community hospitals: a case-case-control study, Ann Pharmacother., 2013, 47:1115-1121.
European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. 2011, Version 1.3, Available from: www.korld.edu.pl/pdf/eucast/EUCAST_breakpoints_1-3popr.pdf.
Żabicka D., Baraniak A., Gniadkowski M., Wykrywanie karbapenemaz – zalecenia 2013, Available from: www.korld.edu.pl/pdf/Wykrywanie karbapenemaz - zalecenia 2013.pdf.
Nordmann P., Dortet L., Poirel L., Carbapenem resistance in Enterobacteriaceae: here is the storm!, Trends Mol Med., 2012, 18:263-272.
Downloads
Published
How to Cite
Issue
Section
Stats
Number of views and downloads: 256
Number of citations: 0